Company Filing History:
2 out of 1,744 
2 out of 5,089 
2 out of 319 
Years Active: 2018-2022
Title: Patricia Busca: Innovator in Skeletal Disorder Treatments
Introduction
Patricia Busca is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the treatment of skeletal disorders. With a focus on the fibroblast growth factor receptor 3 (FGFR3), her work has the potential to impact many lives.
Latest Patents
Patricia Busca holds 2 patents related to her innovative research. Her latest patents include an antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or prevention of skeletal disorders linked with abnormal activation of FGFR3. This invention addresses the treatment or prevention of skeletal disorders, particularly those developed by patients exhibiting abnormal increased activation of FGFR3, especially through the expression of a constitutively activated mutant of FGFR3.
Career Highlights
Throughout her career, Patricia has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Patricia has collaborated with notable colleagues, including Laurence Legeai-Mallet and Arnold Munnich. These partnerships have furthered her research and contributed to advancements in the treatment of skeletal disorders.
Conclusion
Patricia Busca's work exemplifies the impact of innovation in medical research, particularly in addressing skeletal disorders. Her contributions through patents and collaborations highlight her commitment to improving patient outcomes.